Text

Estrogen and gut microbiome-brain axis interactions in fear extinction

A recent review highlights that changes in fear-related mental health conditions are observed when the gut microbiota is altered or removed.

New study shows Probi strain supports and improves cognitive performance

In a newly published study Probi´s proprietary strain L. plantarum HEAL9 (HEAL9™) was shown to significantly improve cognitive performance.

New study asserts resB® Lung Support improves lung function in asthmatic population

A new study asserts resB® Lung Support improves lung function through microbiome-mediated mechanisms along the gut-lung axis in asthmatic population

Antibiotics may alter gut microbes in ways that hinder cancer immunotherapy

The findings of a recent study suggest that targeting the interactions between MAdCAM-1 and specific receptors on the surface of immune cells may help to improve immunotherapy outcomes.

New clinical study shows clear benefits of Probi’s probiotics for Metabolic Health

A new study demonstrated that daily intake of Probi's proprietary strain Lacticaseibacillus paracasei 8700:2 significantly reduced cardiovascular disease risk.

Vaginal seeding may benefit babies born by C-section, small clinical study shows

The findings of a recent study suggest that vaginal seeding is safe and may normalize the gut microbiota in infants born by C-section.

Key immune molecule helps keep commensal microbes in check

IgA can modulate the exposure and immune response to commensal microbes, and its levels determine the severity of immune dysregulation and clinical symptoms in people with IgA deficiency.

Microbiome Movement Drug Development – Congress Report

With all aspects of LBPs covered in the summit, the 8th Microbiome Movement Summit in Boston became the hub for sharing the latest insights in LBP research and development.

Nanomedicine improves symptoms of inflammatory bowel disease in mice

The findings of a new study suggest that the new nanomedicine approach can improve the delivery of TNF-α-siRNA in people with IBD.

Accelerated lung function decline in chronic obstructive pulmonary disease (COPD): a role for airway dysbiosis

Airway dysbiosis was associated with a lung function decline in COPD patients and it might contribute to this phenotype through metabolic interaction with host pathophysiological processes.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top